keyword
https://read.qxmd.com/read/37128710/risk-factors-for-sessile-serrated-lesions-among-chinese-patients-undergoing-colonoscopy
#21
JOURNAL ARTICLE
Ru Zhang, Yunbi Ni, Cosmos Lt Guo, Rashid Ns Lui, William Wk Wu, Joseph Jy Sung, Vincent Ws Wong, Sunny H Wong
BACKGROUND AND AIM: Serrated polyps have been recognized as a premalignant lesion accounting for a significant proportion of colorectal cancer. Limited data are available regarding the risk factors for colorectal sessile serrated lesions (SSLs). We aimed to investigate clinical risk factors of SSLs and compared them with colorectal adenomas in a study population of Chinese individuals. METHODS: A retrospective case-control study was performed in an academic tertiary-referral center in Hong Kong...
May 1, 2023: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/37088008/innovative-accumulative-risk-assessment-strategy-of-co-exposure-of-as-and-pb-in-medical-earthworms-based-on-in-vivo-in-vitro-correlation
#22
JOURNAL ARTICLE
Tian-Tian Zuo, Jia Zhu, Fei Gao, Ji-Shuang Wang, Qing-Hui Song, Hai-Yan Wang, Lei Sun, Wan-Qiang Zhang, De-Juan Kong, Yuan-Sheng Guo, Jian-Bo Yang, Feng Wei, Qi Wang, Hong-Yu Jin, Shuang-Cheng Ma
Recent studies on risks assessment of heavy metal(loid) are usually based on their total concentrations. Nevertheless, such an analysis does not assess their real amounts absorbed by human body. To scientifically assess the health risks, in this study medical earthworms were analyzed for relative bioavailability (RBA) of arsenic (As) and lead (Pb) using a multiple gavage mouse model with liver, kidneys, brain, and leg bones as biomarkers for the first time. Metal(loid) bioaccessibility was determined using in vitro physiologically based extraction (PBET) assay...
April 18, 2023: Environment International
https://read.qxmd.com/read/36990676/efficacy-toxicities-and-prognostic-factors-of-stereotactic-body-radiotherapy-for-unresectable-liver-metastases
#23
JOURNAL ARTICLE
C K K Choi, C H M Ho, M Y P Wong, R W K Leung, F C S Wong, S Y Tung, F A S Lee
INTRODUCTION: This study aims to determine the outcomes of stereotactic body radiotherapy (SBRT) for liver metastases in patients not eligible for surgery. METHODS: This study included 31 consecutive patients with unresectable liver metastases who received SBRT between January 2012 and December 2017; 22 patients had primary colorectal cancer and nine patients had primary non-colorectal cancer. Treatments ranged from 24 Gy to 48 Gy in 3 to 6 fractions over 1 to 2 weeks...
March 30, 2023: Hong Kong Medical Journal
https://read.qxmd.com/read/36915244/prediction-of-cancer-incidence-and-mortality-in-korea-2023
#24
JOURNAL ARTICLE
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
PURPOSE: This study aimed to report the projected cancer incidence and mortality for the year 2023 to estimate Korea's current cancer burden. MATERIALS AND METHODS: Cancer incidence data from 1999 to 2020 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2021 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2023...
March 10, 2023: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/36907570/overview-of-asian-clinical-practice-guidelines-for-the-management-of-hepatocellular-carcinoma-an-asian-perspective-comparison
#25
REVIEW
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Hepatocellular carcinoma (HCC) is highly prevalent and the third most common cause of cancer-related death in Asia. In contrast to the West, the main etiology of HCC in many Asian countries except Japan is chronic hepatitis B virus infection. Differences in the major causes of HCC lead to significant clinical and treatment differences. This review summarizes and compares guidelines on managing HCC from China, Hong Kong, Taiwan, Japan, and South Korea. From oncology and socio-economic perspectives, factors such as underlying diseases, staging methods, government policies, insurance coverage, and medical resources contribute to varying treatment strategies among countries...
April 2023: Clinical and Molecular Hepatology
https://read.qxmd.com/read/36816738/clinical-outcomes-of-gastric-cancer-surgery-after-liver-transplantation
#26
JOURNAL ARTICLE
Sunjoo Kim, Hyuk-Joon Lee, Fadhel Alzahrani, Jeesun Kim, Sa-Hong Kim, Sara Kim, Yo-Seok Cho, Ji-Hyeon Park, Jeong-Moo Lee, Seong-Ho Kong, Do Joong Park, Kyung-Suk Suh, Han-Kwang Yang
PURPOSE: De novo malignancy is common after liver transplantation (LT); however, there are limited reports on the clinical outcomes of gastric cancer surgery after LT. Our study aimed to investigate the feasibility and safety of gastric cancer surgery after LT. METHODS: Seventeen patients underwent gastric cancer surgery after LT at a single institution between January 2013 and June 2021. We retrospectively collected data on surgical complications, survival, and recurrence status of these cases...
February 2023: Annals of Surgical Treatment and Research
https://read.qxmd.com/read/36812124/efficacy-and-safety-of-lenvatinib-in-patients-with-recurrent-hepatocellular-carcinoma-after-liver-transplantation
#27
JOURNAL ARTICLE
Kyunghye Bang, Andrea Casadei-Gardini, Changhoon Yoo, Massimo Iavarone, Min-Hee Ryu, Sook Ryun Park, Hyung-Don Kim, Young-In Yoon, Dong-Hwan Jung, Gil-Chun Park, Chul-Soo Ahn, Deok-Bog Moon, Shin Hwang, Ki-Hun Kim, Gi-Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L Chan, Massimo De Giorgio, Baek-Yeol Ryoo, Sung-Gyu Lee
INTRODUCTION: Lenvatinib is approved for the treatment of patients with metastatic or recurrent hepatocellular carcinoma (HCC); however, clinical outcomes of lenvatinib therapy in patients with post-liver transplantation (LT) HCC recurrence remain unclear. We investigated the efficacy and safety of lenvatinib in patients with post-LT HCC recurrence. METHODS: This multinational, multicenter, retrospective study included 45 patients with recurrent HCC after LT who received lenvatinib at six institutions in three countries (Korea, Italy, and Hong Kong) from June 2017 to October 2021...
February 2023: Cancer Medicine
https://read.qxmd.com/read/36751987/pd-l1-regulates-epithelial-mesenchymal-transition-and-cancer-stem-cell-phenotypes-in-hepatocellular-carcinoma-through-sgk2-%C3%AE-catenin-signaling-pathway
#28
JOURNAL ARTICLE
Xin Kong, Hong Peng, Peng Liu, Xiao Fu, Ni Wang, Dazhi Zhang
PD-L1 plays an important role in the occurrence of Hepatocellular Carcinoma (HCC). Present study indicated that epithelial-mesenchymal transition (EMT) and induction of cancer stem cell (CSC)-like properties contribute to metastasis of cancers. However, the molecular mechanisms underlying PD-L1 and EMT and CSC phenotypes in HCC remain to be elucidated. Here, we report that PD-L1 regulates not only the epithelial-mesenchymal transition but also the stem-like transition in liver cancer cells. We observed high PD-L1 expression in CD133+ liver CSCs and CSC-enriched tumorspheres...
February 8, 2023: Cancer Science
https://read.qxmd.com/read/36680190/domestic-cat-hepadnavirus-molecular-epidemiology-and-phylogeny-in-cats-in-hong-kong
#29
JOURNAL ARTICLE
Paolo Capozza, Maura Carrai, Yan Ru Choi, Thomas Tu, Omid Nekouei, Gianvito Lanave, Vito Martella, Julia A Beatty, Vanessa R Barrs
Domestic cat hepadnavirus (DCH) is an emerging virus related to the hepatitis B virus (HBV). The pathogenic potential of DCH in cats remains to be established. The molecular prevalence of DCH varies widely in the regions investigated so far. The aim of this study was to determine the prevalence, load, and risk factors for DCH detection among cats in Hong Kong, and to generate molecular and epidemiological data on the DCH strains circulating in cats in Hong Kong. DCH DNA was detected using DCH-specific qPCR in 57/513 (11...
January 3, 2023: Viruses
https://read.qxmd.com/read/36577426/clinical-practice-guidelines-and-real-life-practice-on-hepatocellular-carcinoma-the-hong-kong-perspective
#30
REVIEW
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
Hepatocellular carcinoma (HCC) is a major public health burden in Hong Kong, and chronic hepatitis B is the most common HCC etiology in our region. With the high case load, extensive local expertise on HCC has been accumulated. This article summarized local guidelines and real-life practice on HCC management in Hong Kong. For HCC surveillance, liver ultrasound and serum alpha-fetoprotein for periodic screening is recommended in viral hepatitis or cirrhotic patients, and this is adhered to in clinical practice...
April 2023: Clinical and Molecular Hepatology
https://read.qxmd.com/read/36509254/in-vivo-anti-tumor-activity-of-lignosus-rhinocerus-tm02%C3%A2-using-a-mcf7-xenograft-ncr-nude-mice-model
#31
JOURNAL ARTICLE
Min Jia Ng, Boon Hong Kong, Kean Hooi Teoh, Yeannie Hui-Yeng Yap, Szu Ting Ng, Chon Seng Tan, Muhammad Fazril Mohamad Razif, Shin Yee Fung
ETHNOPHARMACOLOGICAL RELEVANCE: Lignosus rhinocerus (Cooke) Ryvarden (also known as Tiger Milk mushroom, TMM), is a basidiomycete belonging to the Polyporaceae family. It has been documented to be used by traditional Chinese physicians and indigenous people in Southeast Asia to treat a variety of illnesses, such as gastritis, arthritis, and respiratory conditions, as well as to restore patients' physical well-being. TMM has also been used in folk medicine to treat cancer. For example, people from the indigenous Kensiu tribe of northeast Kedah (Malaysia) apply shredded TMM sclerotium mixed with water directly onto breast skin to treat breast cancer, while Chinese practitioners from Hong Kong, China prescribe TMM sclerotium as a treatment for liver cancer...
December 9, 2022: Journal of Ethnopharmacology
https://read.qxmd.com/read/36471935/-chemical-constituents-and-anti-liver-fibrosis-mechanism-of-meconopsis-quintuplinervia-based-on-uplc-q-exactive-ms-ms-and-network-pharmacology
#32
JOURNAL ARTICLE
Yuan-Lin Kong, Jian-Guang Zhang, Hong-Na Su, Mu-Jia LA, Jian-Long Lan, Zheng-Ming Yang, Quan Ma, Yan-Fei Huang, Yuan Liu
In this study, UPLC-Q-Exactive-MS/MS was used to rapidly analyze the chemical constituents of Meconopsis quintupli-nervia, and the anti-liver fibrosis mechanism of M. quintuplinervia was preliminarily analyzed by network pharmacology, molecular docking, and cell experiments. The chemical constituents of M. quintuplinervia were identified according to the information of MS~1 and MS~2, as well as the data in the literature and databases. SwissTargetPrediction and TargetNet were used to predict the potential targets...
November 2022: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/36463985/risk-of-hepatic-decompensation-but-not-hepatocellular-carcinoma-decreases-over-time-in-patients-with-hepatitis-b-surface-antigen-loss
#33
JOURNAL ARTICLE
Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Mandy Sze-Man Lai, Jimmy Che-To Lai, Vicki Wing-Ki Hui, Lilian Yan Liang, Yee-Kit Tse, Henry Lik-Yuen Chan, Grace Lai-Hung Wong
BACKGROUND & AIMS: We examined the long-term incidence of hepatocellular carcinoma (HCC) and hepatic decompensation among chronic hepatitis B (CHB) patients who have achieved hepatitis B surface antigen (HBsAg) seroclearance. METHODS: All adult CHB-monoinfected patients who cleared HBsAg between January 2000 and December 2020 were identified using a territory-wide database in Hong Kong. Patients who underwent liver transplantation and/or developed HCC before HBsAg seroclearance or less than 6 months follow-up were excluded...
March 2023: Journal of Hepatology
https://read.qxmd.com/read/36399356/detecting-liver-cancer-using-cell-free-dna-fragmentomes
#34
JOURNAL ARTICLE
Zachariah H Foda, Akshaya V Annapragada, Kavya Boyapati, Daniel C Bruhm, Nicholas A Vulpescu, Jamie E Medina, Dimitrios Mathios, Stephen Cristiano, Noushin Niknafs, Harry T Luu, Michael G Goggins, Robert A Anders, Jing Sun, Shruti H Mehta, David L Thomas, Gregory D Kirk, Vilmos Adleff, Jillian Phallen, Robert B Scharpf, Amy K Kim, Victor E Velculescu
Liver cancer is a major cause of cancer mortality worldwide. Screening individuals at high-risk, including those with cirrhosis and viral hepatitis, provides an avenue for improved survival, but current screening methods are inadequate. In this study, we used whole-genome cell-free DNA fragmentome analyses to evaluate 724 individuals from the US, EU, or Hong Kong with hepatocellular carcinoma (HCC) or who were at average or high-risk for HCC. Using a machine learning model that incorporated multi-feature fragmentome data, the sensitivity for detecting cancer was 88% in an average risk population at 98% specificity, and 85% among high-risk individuals at 80% specificity...
November 18, 2022: Cancer Discovery
https://read.qxmd.com/read/36340319/clinical-profile-patterns-of-care-adherence-to-guidelines-in-patients-with-hepatocellular-carcinoma-prospective-multi-center-study
#35
JOURNAL ARTICLE
Akash Shukla, Shraddha Patkar, Sridhar Sundaram, Samir R Shah, Meghraj Ingle, Amit Gupta, Amrit Gopan, Mrunal Kamat, Ravi Mohanka, Sandeep Singh, Swapnil Walke, Vikas Pandey, Mahesh Goel
BACKGROUND AND AIMS: Increasing incidence of hepatocellular carcinoma (HCC) in India is a matter of concern and need for adequate profiling and streamlining management strategies cannot be over-emphasized. METHODS: This is a prospective multi-centric observational cohort study comprising of an oncology center, one university tertiary hospital with specialized hepatology service, one public hospital with gastroenterology service, and a private liver transplant center located within a 3-km radius...
2022: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36314035/ideal-patients-for-liver-resection-in-barcelona-clinic-liver-cancer-or-hong-kong-liver-clinic-systems-for-hepatocellular-carcinoma-conservative-or-aggressive
#36
JOURNAL ARTICLE
Jun-Xiang Li, Peng Zhou, De-Hua Chang, Yao Tong, Yan Bao, Yu-Dong Xiao, Shi Zhou, Wen-Wu Cai
Background: Both the Barcelona Clinic Liver Cancer (BCLC) staging and the Hong Kong Liver Cancer (HKLC) staging have their own definitions of ideal patients for liver resection (IPLR) in hepatocellular carcinoma (HCC). This study aimed to compare the prognosis of IPLRs between the BCLC and HKLC staging systems, and to identify patients who may benefit from liver resection (LR) in the HKLC staging but beyond the BCLC staging. Methods: This retrospective study evaluated 1,296 consecutive patients with HCC who underwent LR between August 2013 and April 2021 (457 patients and 1,046 patients were IPLR according to the BCLC and HKLC staging systems, respectively)...
2022: Frontiers in Medicine
https://read.qxmd.com/read/36158587/systemic-treatment-of-advanced-unresectable-hepatocellular-carcinoma-after-first-line-therapy-expert-recommendations-from-hong-kong-singapore-and-taiwan
#37
REVIEW
Thomas Yau, David Tai, Stephen Lam Chan, Yi-Hsiang Huang, Su Pin Choo, Chiun Hsu, Tan To Cheung, Shi-Ming Lin, Wei Peng Yong, Joycelyn Lee, Thomas Leung, Tracy Shum, Cynthia S Y Yeung, Anna Yin-Ping Tai, Ada Lai Yau Law, Ann-Lii Cheng, Li-Tzong Chen
BACKGROUND: Asia has a high burden of hepatocellular carcinoma (HCC) due to the high rates of chronic hepatitis B infection and accounts for 70% of HCC cases globally. In the past 20 years, the systemic treatment landscape of advanced HCC has evolved substantially - from tyrosine kinase inhibitors to immune-oncology agents plus anti-vascular endothelial growth factor agents. The appropriate sequence of therapies has become critical in optimizing patient outcomes given the increase in systemic therapeutic options...
September 2022: Liver Cancer
https://read.qxmd.com/read/36017842/integrative-multi-omics-analysis-of-identified-ferroptosis-marker-rpl8-as-a-candidate-oncogene-correlates-with-poor-prognosis-and-immune-infiltration-in-liver-cancer
#38
JOURNAL ARTICLE
Shunli Fan, Sai Zhang, Dejun Kong, Hao Wang, Yuan Shi, Zhenglu Wang, Hong Zheng
BACKGROUND: Liver Hepatocellular Carcinoma (LIHC) is characterized with high malignancy, poor prognosis, and high recurrence rate worldwide. The role of ferroptosis in tumorigenesis and progression has been confirmed in previous studies. However, the multi-omics analysis in liver cancer of ferroptosis-markers RPL8 remains to be elucidated. METHODS: In this analysis, the RPL8 mRNA expression was analyzed via the GEPIA, TIMER and UALCAN databases. In addition, we verified the mRNA expression of RPL8 by qRT-PCR experiment...
August 23, 2022: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/35868902/risk-factors-and-long-term-prognosis-of-beyond-milan-recurrence-after-hepatectomy-for-bclc-stage-0-a-hepatocellular-carcinoma-a-large-scale-multicenter-study
#39
MULTICENTER STUDY
Zi-Han Feng, Ming-Da Wang, Zhong Chen, Li-Yang Sun, Xiao Xu, Qing-Yu Kong, Zi-Xiang Chen, Yong-Yi Zeng, Ying-Jian Liang, Zhi-Yu Chen, Hong Wang, Ya-Hao Zhou, Ting-Hao Chen, Lan-Qing Yao, Chao Li, Timothy M Pawlik, Wan Yee Lau, Feng Shen, Tian Yang
BACKGROUND: Data on recurrence are important to inform surveillance and improve long-term surgical outcomes for patients with hepatocellular carcinoma. We sought to identify risk factors and long-term prognosis among patients who experienced beyond-Milan recurrence after hepatectomy for early-stage hepatocellular carcinoma. METHODS: Patients who underwent hepatectomy for Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma were identified from a multi-institutional database...
October 2022: Surgery
https://read.qxmd.com/read/35864571/universal-hbv-vaccination-dramatically-reduces-the-prevalence-of-hbv-infection-and-incidence-of-hepatocellular-carcinoma
#40
JOURNAL ARTICLE
Grace Lai-Hung Wong, Vicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Lilian Yan Liang, Xinrong Zhang, Yee-Kit Tse, Jimmy Che-To Lai, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong
BACKGROUND: Universal vaccination of newborns with hepatitis B virus (HBV) vaccine is the most important strategy to prevent chronic HBV infection and its complications of which hepatocellular carcinoma (HCC) as the deadliest. AIMS: To evaluate the impact of universal HBV vaccination on the prevalence of chronic HBV infection, and the incidences of HCC and hepatic events in young adults born before and after the introduction of the universal HBV vaccination programme in 1988 in Hong Kong METHODS: This was a territory-wide retrospective observational cohort study of consecutive adult subjects born in 1970-2002 with hepatitis B surface antigen (HBsAg) checked...
July 21, 2022: Alimentary Pharmacology & Therapeutics
keyword
keyword
75498
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.